The relationships among dyspnoea, health-related quality of life and psychological factors in sarcoidosis

Respirology

Volumn 19, Issue 7, 2014, Pages 1019-1024

  De Boer, Sally ^a   Kolbe, John ^a   Wilsher, Margaret L ^a  

^a AUCKLAND CITY HOSPITAL   (New Zealand)

Author keywords

Depression; Dyspnoea; Health status; Hyperventilation; Sarcoidosis

Indexed keywords

CORTICOSTEROID; METHOTREXATE;

ADULT; ANXIETY; ARTICLE; CORTICOSTEROID THERAPY; DEPRESSION; DISEASE DURATION; DYSPNEA; EXERCISE; FEMALE; FORCED EXPIRATORY VOLUME; FORCED VITAL CAPACITY; HOSPITAL ANXIETY AND DEPRESSION SCALE; HUMAN; LUNG FUNCTION; MAJOR CLINICAL STUDY; MALE; NAMED INVENTORIES, QUESTIONNAIRES AND RATING SCALES; NIJMEGEN QUESTIONNAIRE; PSYCHOLOGICAL ASPECT; QUALITATIVE RESEARCH; QUALITY OF LIFE; QUESTIONNAIRE; SARCOIDOSIS; ST. GEORGE RESPIRATORY QUESTIONNAIRE; TREND STUDY; COHORT ANALYSIS; COMPLICATION; HEALTH STATUS; HYPERVENTILATION; LUNG DIFFUSION CAPACITY; LUNG SARCOIDOSIS; MIDDLE AGED; PATHOPHYSIOLOGY; PREVALENCE; PSYCHOLOGY; VITAL CAPACITY;

ADULT; ANXIETY; COHORT STUDIES; DEPRESSION; DYSPNEA; FEMALE; FORCED EXPIRATORY VOLUME; HEALTH STATUS; HUMANS; HYPERVENTILATION; MALE; MIDDLE AGED; PREVALENCE; PULMONARY DIFFUSING CAPACITY; QUALITY OF LIFE; SARCOIDOSIS, PULMONARY; VITAL CAPACITY;

EID: 84908621191     PISSN: 13237799     EISSN: 14401843     Source Type: Journal    
DOI: 10.1111/resp.12359     Document Type: Article

References (34)

1. Wirnsberger RM, de Vries J, Breteler MH, van Heck GL, Wouters E F M, Drent M. Evaluation of quality of life in sarcoidosis patients. Respir. Med. 1998;92:750-6.
2. De Vries J, Drent M, Van Heck GL, Wouters E F M. Quality of life in sarcoidosis: a comparison between members of a patient organisation and a random sample. Sarcoidosis Vasc. Diffuse Lung Dis. 1998;15:183-8.
3. Chang B, Steimel J, Moller DR, Baughman RP, Judson MA, Yeager H, Teirstein AS, Rossman MD, Rand CS. Depression in sarcoidosis. Am. J. Respir. Crit. Care Med. 2001;163:329-34.
4. Matthews JI, Hooper RG. Exercise testinginpulmonarysarcoidosis. Chest 1983;83:75-81.
5. Baughman RP, Sparkman BK, Lower EE. Six-minute walk test and health status assessment in sarcoidosis. Chest 2007;132:207-13.
6. Sietsema KE, Kraft M, Ginzton L, Sharma OP. Abnormal oxygen uptake responses to exercise in patients with mild pulmonary sarcoidosis. Chest 1992;102:838-45.
7. Cox CE, Donohue JF, Brown CD, Kataria YP, Judson MA. The Sarcoidosis Health Questionnaire: a new measure of healthrelated quality of life. Am. J. Respir. Crit. Care Med. 2003;168:323-9.
8. Drent M, De Vries J, Lenters M, Larners R J S, Rothkranz-Kos S, Wouters E F M, van Dieijen-Visser MP, Verschakelen JA. Sarcoidosis: assessment of disease severity using HRCT. Eur. Radiol. 2003;13:2462-71.
9. Gibbons WJ, Levy RD, Nava S, Malcolm I, Marin JM, Tradif C, Magder S, Lisbona R, Cosio MG. Subclinical cardiac dysfunction in sarcoidosis. Chest 1991;100:44-50.
10. Gvozdenovic BS, Mihailovic-Vucinic V, Ilic-Dudvarski A, Zugic V, Judson MA. Differences in symptom severity and health status impairment between patients with pulmonary and pulmonary plus extrapulmonary sarcoidosis. Respir. Med. 2008;102:1636-42.
11. Michielsen HJ, Peros-Golubicic T, Drent M, De Vries J. Relationship between symptoms and quality of life in a sarcoidosis population. Respiration 2007;74:401-5.
12. Folgering H. The pathophysiology of hyperventilation syndrome. Monaldi Arch. Chest Dis. 1999;54:365-72.
13. Lewis RA, Howell JB. Definition of the hyperventilation syndrome. Bull. Eur. Physiopathol. Respir. 1986;22:201-5.
14. Cox CE, Donohue JF, Brown CD, Kataria YP, Judson MA. Healthrelated quality of life of persons with sarcoidosis. Chest 2004;125:997-1004.
15. Wilsher ML, Hopkins R, Young LM, Cornere M, West T. Characteristics of sarcoidosis in Maori and Pacific Islanders. Am. J. Respir. Crit. Care Med. 2005;171:A864.
16. Miller A, Brown LK, Sloane MF, Bhuptani A, Teirstein AS. Cardiorespiratory responses to incremental exercise in sarcoidosis patients with normal spirometry. Chest 1995;107:323-9.
17. Wirnsberger RM, Drent M, Hekelaar N, Breteler M H M, Drent S, Wouters E F M, Dekhuijzen P N R. Relationship between respiratory muscle function and quality of life in sarcoidosis. Eur. Respir. J. 1997;10:1450-5.
18. Parshall MB, Schwartzstein RM, Adams L, Banzett RB, Manning HL, Bourbeau J, Calverley PM, Gift AG, Harver A, Lareau SC et al. An official American Thoracic Society statement: update on the mechanisms, assessment, and management of dyspnea. Am. J. Respir. Crit. Care Med. 2012;185:435-52.
19. O'Donnell DE, Bertley JC, Chau LK, Webb KA. Qualitative aspects of exertional breathlessness in chronic airflow limitation: pathophysiologic mechanisms. Am. J. Respir. Crit. Care Med. 1997;155:109-15.
20. Simon PM, Schwartzstein RM, Weiss JW. Distinguishable sensations of breathlessness induced in normal volunteers. Am. Rev. Respir. Dis. 1989;140:1021-7.
21. Simon PM, Schwartzstein RM, Weiss JW, Fencl V, Teghtsoonian M, Weinberger SE. Distinguishable types of dyspnea in patients with shortness of breath. Am. Rev. Respir. Dis. 1990;142:1009-14.
22. Roca J, Burgos F, Sunyer J, Saez M, Chinn S, Ant JM, Rodriguez-Roisin R, Quanjer PH, Nowaki D, Burney P. References values for forced spirometry. Group of the European Community Respiratory Health Survey. Eur. Respir. J. 1998;11:1354-62.
23. Milivojevic-Poleksic L, Wells AU, Moody A, Fergusson W, Tukuitonga C, Kolbe J. Spirometric lung volumes in the adult Pacific Islander population: comparison with predicted values in a European population. Respirology 2001;6:247-53.
24. O'Donnell DE, Chau LK, Webb KA. Qualitative aspects of exertional dyspnea in patients with interstitial lung disease. J. Appl. Physiol. 1998;84:2000-9.
25. Jones PW, Quirk FH, Baveystock CM, Littlejohns P. A self-complete measure of health status for chronic airflow limitation. The St. George's Respiratory Questionnaire. Am. Rev. Respir. Dis. 1992;145:1321-7.
26. Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr. Scand. 1983;67:361-70.
27. van Dixhoorn J, Duivenvoorden HJ. Efficacy of Nijmegen Questionnaire in recognition of the hyperventilation syndrome. J. Psychosom. Res. 1985;29:199-206.
28. Drent M, Wirnsberger RM, Breteler MH, Kock LM, de Vries J, Wouters EF. Quality of life and depressive symptoms in patients suffering from sarcoidosis. Sarcoidosis Vasc. Diffuse Lung Dis. 1998;15:59-66.
29. Brazier JE, Harper R, Jones N M B, O'Cathain A, Thomas KJ, Usherwood T, Westlake L. Validating the SF-36 health survey questionnaire: new outcome measure for primary care. BMJ 1992 18;305:160-4.
30. Hinz A, Fleischer M, Brahler E, Wirtz H, Bosse-Henck A. Fatigue in patients with sarcoidosis, compared with the general population. Gen. Hosp. Psychiatry 2011;33:462-8.
31. Eaton T, Young P, Fergusson W, Garrett JE, Kolbe J. The Dartmouth COOP Charts: a simple, reliable, valid and responsive quality of life tool for chronic obstructive pulmonary disease. Qual. Life Res. 2005;14:575-85.
32. Ireland J, Wilsher M. Perceptions and beliefs in sarcoidosis. Sarcoidosis Vasc. Diffuse Lung Dis. 2010;27:36-42.
33. Eaton T, Young P, Milne D, Wells AU. Six-minute walk, maximal exercise tests: reproducibility in fibrotic interstitial pneumonia. Am. J. Respir. Crit. Care Med. 2005;171:1150-7.
34. Kolbe J, Fergusson W, Vamos M, Garrett J. Case-control study of severe life threatening asthma (SLTA) in adults: psychological factors. Thorax 2002;57:317-22.